FindTrial
Sign In

A randomized clinical control Stage III trial of an intensive comprehensive education course to impact stress indicators and medical compliance among Chinese breast cancer patients after postoperative radiotherapy period

A randomized clinical control Stage III trial of an intensive comprehensive education course to impact stress indicators and medical compliance among Chinese breast cancer patients after postoperative radiotherapy period

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-16008818
Enrollment
Unknown
Registered
2016-07-11
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Group A: Intervention Group:Intensive Education on BC knowledge
Group B: Control Group:routine education on BC knowledge

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and more; 2. BCS or MRM; 3. pathological diagnosis of breast cancer.

Exclusion criteria

Exclusion criteria: 1. male; 2. double breast cancer.

Design outcomes

Primary

MeasureTime frame
Distress Thermometer;Hormonal drug compliance;—

Secondary

MeasureTime frame
Quality of Life;tumor recurrence;OS & DFS;—

Countries

China

Contacts

Public ContactZhensheng Li

Radiotherapy Department, Fourth Hospital, Hebei Medical University

Zhensheng.Li.mdphd@gmail.com+86 15031101916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026